Development of Radiolabeled Membrane Type-1 Matrix Metalloproteinase Activatable Cell Penetrating Peptide Imaging Probes

Development of Radiolabeled Membrane Type-1 Matrix Metalloproteinase Activatable Cell Penetrating Peptide Imaging Probes

Membrane type-1 matrix metalloproteinase (MT1-MMP or MMP-14) plays an important role in adverse cardiac remodelling. Here, we aimed to develop radiolabeled activatable cell penetrating peptides (ACPP) sensitive to MT1-MMP for the detection of elevated MT1-MMP levels in adverse cardiac remodelling. T...

Full description

Bibliographic Details
Main Authors:	Sander M. J. van Duijnhoven, Marc S. Robillard, Klaas Nicolay, Holger Grüll
Format:	Article
Language:	English
Published:	MDPI AG 2015-07-01
Series:	Molecules
Subjects:	molecular imaging activatable cell penetrating peptide matrix metalloproteinase-14 membrane type-1 matrix metalloproteinase radiolabeling myocardial infarction peptide chemistry
Online Access:	http://www.mdpi.com/1420-3049/20/7/12076

Similar Items

Synthesis of Fluorogenic Probes Specific for Matrix Metalloproteinase 13

Gelatinase Biosensor Reports Cellular Remodeling During Epileptogenesis
by: Nathalie Bouquier, et al.
Published: (2020-04-01)

Matrix metalloprotein-triggered, cell penetrating peptide-modified star-shaped nanoparticles for tumor targeting and cancer therapy
by: Fangyuan Guo, et al.
Published: (2020-03-01)

Evaluation of the Effects of Increased Parathyroid Hormone (PTH) Following Myocardial Infarction on the Expressions Level of Matrix Metalloproteinase 9 and Tissue Inhibitor Metalloproteinase
by: Faezeh Hoseini, et al.
Published: (2017-11-01)

Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
by: Helena Laronha, et al.
Published: (2021-03-01)

Effect of Smoking on Metalloproteinases (MMPs) Activity in Patients with Acute Myocardial Infarction (AMI)
by: Sreekanth K Sivaraman, et al.
Published: (2014-02-01)

Tumor Activated Cell Penetrating Peptides to Selectively Deliver Immune Modulatory Drugs
by: Dina V. Hingorani, et al.
Published: (2021-03-01)

Expression of matrix metalloproteinase-2 and 9 with their inhibitors, tissue inhibitors of metalloproteinase-1 and 2 in oral lichen planus
by: Natheer Hashim Al-Rawi, et al.
Published: (2014-01-01)

The relationship between the first episode of wheezing and matrix metalloproteinases-9 and MMP-2 and tissue inhibitors of MMP-1 levels in preterm infants
by: Rabia Gonul Sezer, et al.
Published: (2013-01-01)

Perioceutics: Matrix metalloproteinase inhibitors as an adjunctive therapy for inflammatory periodontal disease
by: Esther Nalini Honibald, et al.
Published: (2012-01-01)

A STUDY ON THE CLINICAL RELEVANCE OF METALLOPROTEINASE INHIBITION

Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis
by: Krzysztof Szymanowski, et al.
Published: (2016-09-01)

Role of Gene Polymorphisms of Matrix Metalloproteinases-2, -3 and -13 in the Development of Coronary Artery Atherosclerosis in Patients with Primary Polyosteoarthrosis
by: O. O. Portyannikova, et al.
Published: (2020-03-01)

Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014-07-01)

Peptide-Based Inhibitors of ADAM and ADAMTS Metalloproteinases
by: Stefano Pluda, et al.
Published: (2021-07-01)

ELISA study of matrix metalloproteinases 2, 7, 9 and their type 2 tissue inhibitor in the tumors of gastric cancer patients: clinical and pathologic correlations
by: E. S. Gershtein, et al.
Published: (2018-09-01)

Metalloproteinase and tissue inhibitor of metalloproteinase in tuberculosis and malignant pleural effusion
by: Nesriene Mohamad El Margoushy, et al.
Published: (2013-04-01)

Expressions of matrix metalloproteinase-2 and extracellular matrix metalloproteinase inducer in retinoblastoma
by: Yu-Hong Cheng, et al.
Published: (2015-07-01)

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
by: Griselda A Cabral-Pacheco, et al.
Published: (2020-12-01)

Influence of thrombolytic therapy on the condition of matrix metalloproteinase and their inhibitors system in patients with Q-wave myocardial infarction
by: S. M. Kyselov
Published: (2014-08-01)

The Role of Matrix Metalloproteinases in Colorectal Cancer
by: Anan H. Said, et al.
Published: (2014-02-01)

Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017-01-01)

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review
by: Joanna Szydełko, et al.
Published: (2019-09-01)

Immunoinformatics design of multiepitopes peptide-based universal cancer vaccine using matrix metalloproteinase-9 protein as a target
by: Abdelrahman H. Abdelmoneim, et al.
Published: (2021-01-01)

Association between expression of tissue inhibitors of metalloproteinases-1, matrix metalloproteinase-2, and matrix metalloproteinase-9 genes and axillary lymph nodes metastasis in patients with breast cancer
by: Alireza Abdollahi, et al.
Published: (2019-01-01)

Matrix metalloproteinases, inhibitor of metalloproteinases mRNA and protein expression in laryngeal squamous cell carcinoma
by: Weronika Lucas Grzelczyk, et al.
Published: (2019-04-01)

The Product of Matrix Metalloproteinase Cleavage of Doxorubicin Conjugate for Anticancer Drug Delivery: Calorimetric, Spectroscopic, and Molecular Dynamics Studies on Peptide–Doxorubicin Binding to DNA
by: Kamila Butowska, et al.
Published: (2020-09-01)

Activity of matrix metalloproteinases and their tissue inhibitors in serum in chronic granulating periodontitis
by: D. I. Haidash, et al.
Published: (2019-12-01)

Eotaxin-induced expression of membrane type 1 matrix metalloproteinase mRNA in human eosinophils
by: Izumi Kurosaki, et al.
Published: (2000-01-01)

Cell-Penetrating Doxorubicin Released from Elastin-Like Polypeptide Kills Doxorubicin-Resistant Cancer Cells in In Vitro Study
by: Jung Su Ryu, et al.
Published: (2021-01-01)

The Versatile Role of Matrix Metalloproteinase for the Diverse Results of Fibrosis Treatment
by: Hong-Meng Chuang, et al.
Published: (2019-11-01)

SYSTEM OF MATRIX METALLOPROTEINASES IN THE EVALUATION OF LUNG TISSUE DESTRUCTION IN TUBERCULOSIS
by: D. S. Esmedlyaeva, et al.
Published: (2015-08-01)

The Contribution of Serum Anti–cyclic Citrullinated Peptide Antibody and Matrix Metalloproteinase-3 in Predicting the Activity of Rheumatoid Arthritis Disease
by: Aida R. Al-Derzi
Published: (2017-07-01)

Comparison of the prognostic potential of biomechanic stress markers - circulating stromelysin-1, matrix metalloprteinase-9 and N-terminal fragment of brain natriuretic peptide in patients with acute Q-wave myocardial infarction. Results of cohort study
by: T. Samura
Published: (2012-04-01)

Matrix Metalloproteinases in Health and Disease
by: Raffaele Serra
Published: (2020-08-01)

Quercetin prevent proteoglycan destruction by inhibits matrix metalloproteinase-9, matrix metalloproteinase-13, a disintegrin and metalloproteinase with thrombospondin motifs-5 expressions on osteoarthritis model rats
by: Dian Agustina Permatasari, et al.
Published: (2019-01-01)

The predictive function of rates of matrix metalloproteinases/inhibitors system when assessing reparative changes in the lung tissue in those with infiltrate pulmonary tuberculosis
by: D. S. Esmedlyaevа, et al.
Published: (2018-10-01)

Significance of matrix metalloproteinases and their ihhibitors in normal subjects, solid and blood cancer patients
by: Nadezhda Vladimirovna Gaydamaka, et al.
Published: (2009-07-01)

Structure and Function of Human Matrix Metalloproteinases
by: Helena Laronha, et al.
Published: (2020-04-01)

The significance of metalloproteinases and their inhibitors in gastric cancer
by: Marta Łukaszewicz-Zając, et al.
Published: (2009-06-01)